Jarushka Naidoo and Marga Majem
Mar 28, 2025, 14:38
Jarushka Naidoo: Results from the Phase II KROCUS Trial at ELCC 2025 presented by Marga Majem
Jarushka Naidoo, Full Professor and Consultant Medical Oncologist at Royal College of Surgeons in Ireland, shared a post on X:
“ELCC25 Mini Orals
Phase II KROCUS trial: 1L fulzerasib + cetuximab in KRAS G12C+ NSCLC by Marga Majem
– ORR 68.9% (by investigator 80%)
– DCR 100%
– mPFS 12.5m
– very tolerable tox, activity in STK11+, KEAP1+.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 30, 2025, 17:19
Mar 30, 2025, 16:56
Mar 30, 2025, 16:44
Mar 30, 2025, 16:43
Mar 30, 2025, 16:03
Mar 30, 2025, 15:52
Mar 30, 2025, 15:48